218 related articles for article (PubMed ID: 22168789)
21. A multiphase model of the dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alpha2a, lamivudine and combination therapy.
Colombatto P; Civitano L; Bizzarri R; Oliveri F; Choudhury S; Gieschke R; Bonino F; Brunetto MR;
Antivir Ther; 2006; 11(2):197-212. PubMed ID: 16640101
[TBL] [Abstract][Full Text] [Related]
22. Pegylated interferons for chronic hepatitis B.
Craxi A; Cooksley WG
Antiviral Res; 2003 Oct; 60(2):87-9. PubMed ID: 14638403
[TBL] [Abstract][Full Text] [Related]
23. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.
Fan R; Sun J; Yuan Q; Xie Q; Bai X; Ning Q; Cheng J; Yu Y; Niu J; Shi G; Wang H; Tan D; Wan M; Chen S; Xu M; Chen X; Tang H; Sheng J; Lu F; Jia J; Zhuang H; Xia N; Hou J;
Gut; 2016 Feb; 65(2):313-20. PubMed ID: 25586058
[TBL] [Abstract][Full Text] [Related]
24. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study.
Dikici B; Ozgenc F; Kalayci AG; Targan S; Ozkan T; Selimoglu A; Doganci T; Kansu A; Tosun S; Arslan N; Kasirga E; Bosnak M; Haspolat K; Buyukgebiz B; Aydogdu S; Girgin N; Yagci RV
J Gastroenterol Hepatol; 2004 Feb; 19(2):127-33. PubMed ID: 14731120
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic vaccination in chronic hepatitis B.
Senturk H; Tabak F; Akdogan M; Erdem L; Mert A; Ozaras R; Sander E; Ozbay G; Badur S
J Gastroenterol Hepatol; 2002 Jan; 17(1):72-6. PubMed ID: 11895556
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B.
Chen C; Guo SM; Liu B
J Viral Hepat; 2000 May; 7(3):225-9. PubMed ID: 10849265
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.
Zheng Y; Zhao L; Wu T; Guo S; Chen Y; Zhou T
Virol J; 2009 Jul; 6():99. PubMed ID: 19586556
[TBL] [Abstract][Full Text] [Related]
28. Retreatment with higher dose interferon alpha in children with chronic hepatitis B infection.
Ozen H; Koçak N; Yüce A; Gürakan F
Pediatr Infect Dis J; 1999 Aug; 18(8):694-7. PubMed ID: 10462338
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy for children with chronic hepatitis B virus infection.
Dikici B; Bosnak M; Bosnak V; Dagli A; Ece A; Yagci RV; Haspolat K
J Gastroenterol Hepatol; 2002 Oct; 17(10):1087-91. PubMed ID: 12201869
[TBL] [Abstract][Full Text] [Related]
30. Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.
Yoo BC; Kim JH; Kim TH; Koh KC; Um SH; Kim YS; Lee KS; Han BH; Chon CY; Han JY; Ryu SH; Kim HC; Byun KS; Hwang SG; Kim BI; Cho M; Yoo K; Lee HJ; Hwang JS; Kim YS; Lee YS; Choi SK; Lee YJ; Yang JM; Park JW; Lee MS; Kim DG; Chung YH; Cho SH; Choi JY; Kweon YO; Lee HY; Jeong SH; Yoo HW; Lee HS
Hepatology; 2007 Oct; 46(4):1041-8. PubMed ID: 17647293
[TBL] [Abstract][Full Text] [Related]
31. Summaries for patients. Combination therapy for chronic hepatitis B.
Ann Intern Med; 2005 Feb; 142(4):I30. PubMed ID: 15710953
[No Abstract] [Full Text] [Related]
32. Comparison of two different regimens of combined interferon-alpha2a and lamivudine therapy in children with chronic hepatitis B infection.
Kansu A; Doğanci T; Akman SA; Artan R; Kuyucu N; Kalayci AG; Dikici B; Dalgiç B; Selimoğlu A; Kasirga E; Ozkan TB; Kuloğlu Z; Aydoğdu S; Boşnak M; Ertekin V; Tanir G; Haspolat K; Girgin N; Yağci RV
Antivir Ther; 2006; 11(2):255-61. PubMed ID: 16640106
[TBL] [Abstract][Full Text] [Related]
33. Response to interferon-alpha 2a in patients with e antigen-negative chronic hepatitis B.
Kako M; Kanai K; Aikawa T; Iwabuchi S; Takehira Y; Kawasaki T; Tsubouchi H; Hino K; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
J Clin Gastroenterol; 1997 Sep; 25(2):440-5. PubMed ID: 9412946
[TBL] [Abstract][Full Text] [Related]
34. Follow-Up of 108 Patients with Chronic Hepatitis B Virus Infection Treated with Polyethylene Glycol-Conjugated Derivatives of Interferon-Alpha and Monitoring of Off-Treatment Virological Relapse.
Zhou L; He Q; Liu X; Yang X; Ou X; Situ B; Li Y; Pan X; Xu Q
Med Sci Monit; 2022 Mar; 28():e934785. PubMed ID: 35351845
[TBL] [Abstract][Full Text] [Related]
35. Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients.
Kim YJ; Kim K; Hwang SH; Kim SS; Lee D; Cheong JY; Cho SW
Clin Mol Hepatol; 2013 Sep; 19(3):300-4. PubMed ID: 24133668
[TBL] [Abstract][Full Text] [Related]
36. HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases.
Wu S; Luo W; Wu Y; Chen H; Peng J
BMC Gastroenterol; 2020 Apr; 20(1):121. PubMed ID: 32316928
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled, clinical study of thymosin alpha-1 versus interferon-alpha in [corrected] patients with chronic hepatitis B lacking HBeAg in China [corrected].
You J; Zhuang L; Cheng HY; Yan SM; Qiao YW; Huang JH; Tang BZ; Ma YL; Wu GB; Qu JY; Wu RX
J Chin Med Assoc; 2005 Feb; 68(2):65-72. PubMed ID: 15759817
[TBL] [Abstract][Full Text] [Related]
38. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.
Cooksley WG; Piratvisuth T; Lee SD; Mahachai V; Chao YC; Tanwandee T; Chutaputti A; Chang WY; Zahm FE; Pluck N
J Viral Hepat; 2003 Jul; 10(4):298-305. PubMed ID: 12823597
[TBL] [Abstract][Full Text] [Related]
39. Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment.
Zampino R; Marrone A; Cirillo G; del Giudice EM; Utili R; Karayiannis P; Liang TJ; Ruggiero G
J Viral Hepat; 2002 May; 9(3):183-8. PubMed ID: 12010505
[TBL] [Abstract][Full Text] [Related]
40. HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b.
Ma H; Yang RF; Li XH; Jin Q; Wei L
Chin Med J (Engl); 2016 Sep; 129(18):2212-9. PubMed ID: 27625094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
